-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
December 01, 2011 - (b) What are the harms associated with prevention
strategies? … What are the effectiveness and harms of
nonstandard adjunctive interventions? … No data on patient harms or harms to hospital staff due
to preventive interventions were reported. … • Harms were not reported. … • Harms were not reported.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_research-protocol.pdf
January 01, 2020 - What are the potential safety issues and harms of vibration therapy when used
to treat osteoporosis? … What primary and secondary outcomes and harms were examined?
e. … What comparators were used to examine benefits and harms?
f. … What was the length of followup to examine benefits and harms?
g. … What are the possible areas of confusion or potential harms from misuse in
direct-to-consumer marketing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
March 01, 2019 - None of the trials were powered to evaluate harms
as they were all designed to assess efficacy. … Important research gaps must be addressed to
understand more fully the harms associated with
antidepressant … We found no evidence to assess harms for
several therapies of interest including fluvoxamine,
11 … Overall, additional research is needed
to characterize important harms associated with
therapies used … depression in older adults: Research protocol. https://
effectivehealthcare.ahrq.gov/topics/depression-harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - This report addressed benefits and harms of
nonopioid pharmacologic treatments in adults with chronic … All the
studies addressed benefits and five addressed harms. … No change in
conclusions
Harms KQ2. … Tricyclic Antidepressants
Two new RCTs reported harms associated with TCAs versus placebo. … Harms and Adverse Events
a.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
January 01, 2010 - A comprehensive review evaluating the benefits and
harms of screening for MRSA carriage will identify … Morbidity, Mortality, Harms, and Resource Utilization
Because no studies addressed these outcomes, the … Morbidity, Mortality, Harms, and Resource Utilization
Because no studies addressed these outcomes, the … Morbidity, Mortality, Harms, and Resource Utilization
Because no studies addressed these outcomes, the … Morbidity, Mortality, Harms, and Resource Utilization
Because no studies addressed these outcomes, the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_executive.pdf
August 01, 2012 - One-third (16 of 49) of studies reporting harms were
conducted prior to 1980, when nitrous oxide was … Studies reporting harms associated with
sedative analgesic regimens may not translate effectively
to … Most maternal harms reported in the literature were
unpleasant side effects that affect tolerability … Study sizes were inadequate to assess for unusual or
rare harms that might be more serious. … Data
for occupational harms were limited.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
November 19, 2012 - standard set of tests or consensus regarding
whether testing improves treatment outcomes or induces harms … may affect treatment
decisions.4 However, there is no consensus regarding the relative benefits and harms … KQ2: What are the harms and comparative harms of treatments for chronic urinary retention in
adults: … KQ2: What are the harms and comparative harms of treatments for chronic urinary retention in adults: … KQ2a: What patient or condition characteristics (e.g., age, severity, etc.) modify the harms of treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-treatment_research-protocol.pdf
November 08, 2011 - Our review will include an
assessment of adverse effects or harms associated with pressure ulcer treatment … Question 2
What are the harms of treatments for pressure ulcers? … Question 2a
Do the harms of treatment strategies differ according to features of the pressure ulcers … Question 2b
Do the harms of treatment strategies differ according to patient characteristics, including … Question 2c
Do the harms of treatment strategies differ according to patient care settings such as
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bereaved-persons-research-executive-summ.pdf
March 01, 2025 - What are the effectiveness and harms of
universal screening for bereavement and response to loss? … What are the effectiveness, comparative
effectiveness, and harms of interventions for people at risk … What are the effectiveness, comparative
effectiveness, and harms of interventions for people diagnosed … symptoms, more evidence is needed to quantify the presence and
absence of unintended consequences, harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_executive.pdf
March 01, 2013 - studies that do report on harms data were
excluded. … Harms associated with tube feeding include
surgical harms, infection, increased rates of reflux
requiring … One prospective cohort study focused
primarily on harms. … Considerable uncertainty remains concerning harms over
both the short and long term. … Considerable uncertainty remains concerning
harms over both the short and long term.
-
effectivehealthcare.ahrq.gov/products/deprescribing-mhs4/protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
April 01, 2013 - What are the comparative benefits and
harms of erythropoiesis-stimulating agent strategies
and non-ESA … alternative thresholds for
initiating treatment compare regarding their effect on
the benefits and harms … discontinuing therapy or for optimal duration of
therapy compare regarding their effect on the benefits
and harms … It is unknown whether
dosing practices and overall ESA exposure influence
harms.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
May 01, 2022 - No adverse events were reported in the NSAID arm; other
harms were not reported. … Harms
were not reported. … harms, infections,
cardiovascular events, cognitive harms, and psychological harms (e.g., depression … harms, cardiovascular-
B-3
related harms, kidney-related harms, falls, fractures, motor vehicle … accidents,
endocrinological harms, infections, cognitive harms, and psychological harms (e.g.,
depression
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
November 03, 2011 - What are the harms from preventive pharmacologic treatments when compared to active
treatments? … Harms:
o All reported adverse reactions and effects (such as anxiety, nausea, vomiting, sleep … Timing
6 months or more; optimally 12 months
Any time of occurrence for the harms
Setting … of drugs in patients with migraine.
48
The EPC will define harms as a totality of
all possible … adverse consequences of an intervention.
48
The EPC will analyze harms regardless of
how authors
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
September 01, 2009 - Combining different types of medications may appear
attractive but could result in more harms, be less … Compared with higher dose statins
and to one another, do combination regimens differ
in benefits and harms … Harms were SAE,
cancer, treatment adherence, withdrawal due to adverse
events, participants with at least … • Harms should be prospectively collected and
comprehensively reported. … Benefits and Harms Within
Subgroups of Patients
• Trials should be conducted in, or oversample,
specific
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
December 01, 2017 - Clinical trials are not powered to detect harms. … Harms included
spotting, elevations in liver function enzymes, and
endometrial hyperplasia. … Harms associated with myomectomy included
transfusion and pelvic organ injury. … Harms did not differ
among techniques. … Seven reported harms
only (i.e., did not report final health outcomes for
effectiveness).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
April 01, 2024 - None of the studies reported rates of unintended harms.
Conclusions. … What is the frequency and severity of harms associated with care transitions?
2. … What patient safety measures or indicators have been used to examine these harms?
3. … What Are the Frequency and Severity of
Harms Associated With Care Transitions? … There are numerous harms associated with care transitions.
-
effectivehealthcare.ahrq.gov/sites/default/files/woolf_eccs2012.pdf
January 01, 2012 - context into
account,
including
the
patient's
values
regarding specific benefits and harms … Services
Task Force: Reaction to the 2009
Mammography Controversy (2
of 2)
• The potential harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - The report will summarize the available
evidence on the comparative efficacy, effectiveness, and harms … KQ5)
Maintenance of remission (KQ2, KQ5)
Associated symptoms (KQ3, KQ5)
Adverse events
Harms … this decision is directly impacted
by a discussion with the health care provider about benefits and harms … ; key question 4 will rate general efficacy/effectiveness as well as
comparative risk for specific harms … ; and key question 5 will also rate comparative
harms.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
March 22, 2016 - KQ 1: In adults with normal cognition, what are the effectiveness, comparative
effectiveness, and harms … Do effectiveness, comparative effectiveness, and harms of interventions differ as
a function of patient … Do effectiveness, comparative effectiveness, and harms of interventions differ as
a function of patient … Any harm associated with
intervention (e.g. drug
side effects, physical
harms, etc.) … For KQ2: To test the efficacy, comparative effectiveness, and harms of
interventions to